Logo

Helicos

SeqLL Withdraws Plans for $8M IPO

The Massachusetts sequencing firm has been selling technology originally developed by Helicos BioSciences and planned to increase marketing with the IPO proceeds.

True Bearing Readies RNA-Based Coronary Artery Disease Diagnostic for FDA Review, Launch
Premium

The company is collecting validation evidence it intends to submit to the FDA next year, which will also support launch of  the test as an LDT.

SeqLL Launches Early Access for Revamped Helicos Platform, Expands Service Business
Premium

The company plans to raise $25 million in a Series B financing round. It is also working on a two-color chemistry and aims to develop an instrument for clinical applications.

China's Direct Genomics Unveils New Targeted NGS System Based on Helicos Tech for Clinical Use
Premium

The company is currently working with three hospitals in China and plans to launch the GenoCare system commercially in 2017.

SeqLL Plans to Revamp Helicos Technology
Premium

This article was originally published Sept. 29.
Sep 18, 2014

SeqLL Raises $1M to Enhance Service Offerings on Helicos Single-Molecule Platform

Mar 11, 2014

Pathogen Search Underscores Need for Validation Steps When Sequencing Ancient Metagenomes
Premium

Nov 8, 2013

Fruit Fly Study Hints at RNA Editing Effect on Transposon-related Gene Silencing

Jun 17, 2013

Bankruptcy Court OKs Helicos' IP License Deals with Illumina, Life Tech, Fluidigm, Complete Genomics; Negotiations Ongoing with Roche

May 17, 2013

Helicos Seeks Bankruptcy Court Approval of Licensing Deals with Illumina, Life Tech, and Fluidigm

Mar 11, 2013

Helicos Seeks Approval to Sell Assets, IP to Employee to Form New Company

Dec 18, 2012

As Helicos Navigates Bankruptcy Process, Details Emerge on Disputes with Creditors and Customers
Premium

Nov 16, 2012

Helicos BioSciences Files for Chapter 11 Bankruptcy Protection

Oct 2, 2012

Paired Ends: Carol Cox, Louise Mawhinney
Premium

Sep 11, 2012

Paired Ends: Ivan Trifunovich, Andrew Senyei, Paul Bianchi, and More
Premium

Sep 7, 2012

Helicos CEO Resigns

Sep 4, 2012

Helicos Considers Next Moves as Remaining Patent in Illumina Suit Is Deemed Invalid
Premium

Sep 4, 2012

Paired Ends: Noubar Afeyan, Peter Barrett, Daniel O'Day, Pascal Soriot, Roland Diggelman
Premium

Aug 30, 2012

Federal Court Rules Helicos Patent Invalid; Company Reaches Payment Agreement with Lenders

Aug 14, 2012

Helicos Q2 Sales Fall on Lower Grant, Service Revenues

Aug 7, 2012

Helicos Licenses Patents to Intelligent Bio-Systems for $1.6M

Jul 10, 2012

Helicos Drops Suit Against Life Tech, Leaving Illumina as Sole Defendant
Premium

May 14, 2012

Helicos Posts Sharp Drop in Q1 Revenues

May 14, 2012

Helicos Confirms Licensing Deal with PacBio as Part of IP Settlement

May 8, 2012

Awaiting Settlement of Patent Suit with PacBio, Helicos Sets Sights on Life Tech and Illumina
Premium

Breaking News
The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.